Anti-LPAAT-θ antibody
Specifications
| Product Cat#: | AB-06-4835 |
| Product type: | Primary antibody |
| Antigen: | LPAAT-θ |
| Immunogen: | The antiserum was produced against synthesized peptide derived from human AGPAT9. AA range: 381-430. |
| Species immunized: | Rabbit |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:400-1:2000); Immunohistochemistry-Paraffin (1:100-300); Immunofluorescence (1:100-1:400) |
| Reactivity: | Human, Mouse, Rat |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 1*PBS buffer (pH7.4), 50% Glycerol, 0.5% BSA, 0.02% NaN3. |
| Concentration: | 1 mg/ml |
| Purity: | Immunogen affinity purified. |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Conjugate: | Non-conjugated |
| Alternative names: | AGPAT9 antibody; GPAT3 antibody; MAG1 antibody; HMFN0839 antibody; Glycerol-3-phosphate acyltransferase 3 antibody; GPAT-3 antibody; 1-acylglycerol-3-phosphate O-acyltransferase 9 antibody; 1-AGP acyltransferase 9 antibody; 1-AGPAT 9 antibody; Acyl-CoA:glycerol-3-phosphate acyltransferase 3 antibody; hGPAT3 antibody; Lung cancer metastas antibody |
Show More
Target information
Converts glycerol-3-phosphate to 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) by incorporating an acyl moiety at the sn-1 position of the glycerol backbone (PubMed:17170135).
Also converts LPA into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (PubMed:19318427).
Provider
Erpantech Laboratory
